bevacizumab April 12, 2017 bevacizumab Trade Name Avastin Orphan Indication Primary peritoneal carcinoma USA Market Approval USA USA Designation Date 2010-11-02 00:00:00 Sponsor Genentech, Inc;1 DNA Way, M/S# 355E;South San Francisco, California, 94080
